The Biggest Challenges Facing Drug Discovery Teams Today
April 8, 2026
Bringing a new therapy from discovery to market is rarely a straight path. In life sciences, innovation often unfolds over 10 to 15 years, and every stage brings challenges that can delay progress, strain resources, or shift priorities.
While scientific breakthroughs are at the heart of drug development, the teams behind them often determine whether programs move forward or stall. From regulatory uncertainty to funding pressure and communication gaps between teams, today’s drug discovery environment demands more than strong science alone. It also requires agility, leadership, and the right talent in place at the right time.
Here are four of the biggest forces shaping innovation in today’s market.
1. Navigating Industry Uncertainty
The life sciences industry is evolving rapidly. Regulatory expectations shift, capital markets fluctuate, and therapeutic priorities can change in response to new data, policy updates, or market demand.
For organizations in discovery and early development, this creates a difficult planning environment. Long-term timelines often need to be balanced with short-term changes in funding, regulation, and strategy.
In these moments, companies benefit from leaders who can stay adaptable while keeping programs aligned with long-term goals. Scientific and regulatory teams need professionals who can anticipate change, communicate clearly, and maintain momentum even when the landscape shifts.
2. Managing Funding Pressure and Resource Constraints
Innovation requires investment, but today’s funding environment continues to put pressure on biotech and pharma organizations alike.
Whether it is reduced research funding, more selective venture capital activity, or internal budget constraints, companies are being asked to do more with less.
This often means leaner teams, tighter timelines, and greater expectations for efficiency. In this environment, every hire becomes critical.
The right talent can speed up decision-making, improve operations, and help organizations stay nimble during periods of uncertainty. The wrong hire, on the other hand, can create delays that affect the entire development timeline.
For growing organizations, strategic hiring is not simply a staffing decision. It is a business decision that directly impacts innovation.
3. Innovating Without a Blueprint
Some of the most exciting areas in life sciences today involve first-in-class science, including novel modalities, new mechanisms of action, AI-enabled discovery, and emerging therapeutic platforms.
But innovation at this level rarely comes with a roadmap. Teams are often doing things for the first time, with limited precedent to guide decision-making. This requires professionals who are comfortable working in ambiguity.
The most effective teams combine deep technical expertise with curiosity, adaptability, and cross-disciplinary thinking. Scientists, regulatory leaders, and operations teams must work together to solve problems that do not yet have established pathways.
Breakthrough science depends not only on innovation itself, but also on the people capable of leading through uncertainty.
4. Improving Collaboration Across Development Functions
Drug discovery is highly collaborative – yet many organizations still face disconnects between research, regulatory, clinical, quality, and commercial teams.
When functions operate independently, communication gaps can slow timelines and create avoidable obstacles later in the process. The most successful organizations build cross-functional alignment early.
When scientific teams collaborate closely with regulatory and operational leadership from the start, programs often move faster and with greater clarity. This alignment helps organizations anticipate downstream challenges before they become major issues.
Innovation moves faster when the right people are working together.
The Human Side of Innovation
At JBK Search, we see firsthand how the right talent helps life sciences organizations move through uncertainty, scale innovation, and bring life-changing therapies closer to patients.
At JBK Search, we see firsthand how the right talent helps life sciences organizations move through uncertainty, scale innovation, and bring life-changing therapies closer to patients.
Science drives discovery, but people drive progress. As the industry continues to evolve, building agile, high-performing teams remains one of the most important investments organizations can make.
Ready to position yourself at the forefront of FDA policy changes? Let's talk about opportunities where your regulatory expertise can make the biggest impact.